Page last updated: 2024-09-04

moxifloxacin and oligonucleotides

moxifloxacin has been researched along with oligonucleotides in 1 studies

Compound Research Comparison

Studies (moxifloxacin)	Trials (moxifloxacin)	Recent Studies (post-2010) (moxifloxacin)	Studies (oligonucleotides)	Trials (oligonucleotides)	Recent Studies (post-2010) (oligonucleotides)
3,157	552	1,690	23,128	245	7,331

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	1 (100.00)	2.80

Authors

Authors	Studies
Alexander, VJ; Balogh, K; Geary, RS; Hurh, E; Karwatowska-Prokopczuk, E; O'Dea, L; Tsimikas, S; Watts, LM	1

Trials

1 trial(s) available for moxifloxacin and oligonucleotides

Article	Year
Treatment with Volanesorsen, a 2'-O-Methoxyethyl-Modified Antisense Oligonucleotide Targeting Nucleic acid therapeutics, 2020, Volume: 30, Issue:4 Topics: Adult; Apolipoprotein C-III; Dose-Response Relationship, Drug; Double-Blind Method; Drug-Related Side Effects and Adverse Reactions; Electrocardiography; Female; Healthy Volunteers; Humans; Hypertriglyceridemia; Male; Moxifloxacin; Oligonucleotides; Oligonucleotides, Antisense; Placebo Effect; RNA, Messenger; Triglycerides	2020

Article

Year

Treatment with Volanesorsen, a 2'-O-Methoxyethyl-Modified Antisense Oligonucleotide Targeting

Nucleic acid therapeutics, 2020, Volume: 30, Issue:4

Topics: Adult; Apolipoprotein C-III; Dose-Response Relationship, Drug; Double-Blind Method; Drug-Related Side Effects and Adverse Reactions; Electrocardiography; Female; Healthy Volunteers; Humans; Hypertriglyceridemia; Male; Moxifloxacin; Oligonucleotides; Oligonucleotides, Antisense; Placebo Effect; RNA, Messenger; Triglycerides

2020